TGT vs TMDX · P/E 17, rev $51.98B vs P/E 17, rev $363.9M
Target Corporation (TGT) versus TransMedics Group Inc (TMDX) — a side-by-side from cached financials, not a winner call.
Target Corporation (TGT) is a discount stores company listed on NYSE. It is led by Michael J. Fiddelke.
TransMedics Group Inc (TMDX) is a medical devices company listed on NASDAQ.
Latest reported TGT revenue for 2026-08-01 was $51.98B. Net income was $2.66B. TGT currently screens at market cap $58.05B and trailing P/E 16.9.
Latest reported TMDX revenue for 2026-06-30 was $363.9M. Net income was $22.0M. TMDX currently screens at market cap $2.53B and trailing P/E 16.8.
TGT currently screens at market cap $58.05B and trailing P/E 16.9. TMDX currently screens at market cap $2.53B and trailing P/E 16.8.
Not investment advice. Open the TGT and TMDX stock pages for the full models.
Not investment advice.